Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 07:30 ET | Source: Swarmer

Swarmer Publishes Letter From Its Chairman, Erik Prince, Outlining Strategy

AUSTIN, Texas, June 11, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc. (“Swarmer”) (NASDAQ: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in...
June 11, 2026 07:30 ET | Source: Midland Exploration Inc.

Midland Identifies Several Lake Bottom Copper Anomalies from Its New High-Resolution Survey Completed on the Lac Bernard Project

MONTREAL, June 11, 2026 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the final results from its 2025 high-resolution lake bottom survey completed on...
June 11, 2026 07:30 ET | Source: Exploration Midland Inc

Midland identifie plusieurs anomalies de cuivre dans les sédiments de fonds de lacs dans le cadre de son nouveau levé à haute résolution sur le projet Lac Bernard

MONTRÉAL, 11 juin 2026 (GLOBE NEWSWIRE) -- Exploration Midland Inc. (« Midland ») (TSX-V : MD) a le plaisir d’annoncer les résultats finaux de son levé de sédiments de fonds de lacs à haute...
June 11, 2026 07:30 ET | Source: Immuneering Corporation

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
June 11, 2026 07:30 ET | Source: Zero Hash

zerohash Adds Support for HYPE, USDC.HYPE, and USDT.HYPE, Expanding Access for One of the Fastest-Growing Technology Ecosystems

zerohash launches support for Hyperliquid assets, enabling clients like Public and Kalshi to offer seamless access to the L1 ecosystem.
June 11, 2026 07:30 ET | Source: Tris Pharma, Inc.

Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026

Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorderFive scientific presentations will feature preclinical and...
June 11, 2026 07:30 ET | Source: Medicus Pharma Ltd

Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...
June 11, 2026 07:30 ET | Source: FLUENT Corp

FLUENT Provides Management Update

TAMPA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a vertically-integrated, multi-state cannabis company, today announced that David...
June 11, 2026 07:30 ET | Source: Helus Pharma

Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference

NEW YORK and TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Helus PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel...
June 11, 2026 07:30 ET | Source: Rafael Holdings, Inc.

Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results

NEWARK, N.J., June 11, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the third quarter fiscal year 2026 ended April 30, 2026. “Yesterday, we...